What role do governments play in innovation?
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

What role do governments play in innovation?

We often hear that governments have little role in innovation, but is that the case?

The life sciences report published by Marks & Clerk last month reveals that many of the most cutting edge advances in genome research are being made as the result of public funding in the sector.

We wrote about the report when it was launched at the BIO convention in San Diego, but we focused on the geographical split in patenting in the genome sector. But another interesting aspect of Marks & Clerk’s research is the public/private split it reveals, and the role of government funding in early stage research.

In particular, the patent application figures for sequencing, personalised medicine and synthetic biology reveal much about the state of the market in each field.

As partner Gareth Williams explains, the prevalence of private companies filing patents for sequencing technology shows a maturity in the market. In contrast, he says that “the high number of filings by public bodies in personalised medicine and particularly in synthetic biology depicts two emerging technologies, with private companies on the whole showing less confidence.”

the-entrepreneurial-state.jpg

I have just been reading the Entrepreneurial State by economist Mariana Mazzucato who writes persuasively about how governments in rich countries have played a crucial role in innovation. They have done so not just by responding to perceived market failures but by actually creating markets by making investments where the risks involved are just too daunting for the private sector to take on. Once that’s done, the private sector can move in and turn innovation into marketable products.

Marks & Clerk’s research seems to support her views. Of course there’s more to innovation than throwing public money at it (or, as the report’s authors put it, “political engagement in itself is not enough to create an industry”). But in an era where many people regard the state as a brake on, if not an outright impediment to, innovation and entrepreneurialism, it is useful to be reminded why that’s not the full picture.

more from across site and ros bottom lb

More from across our site

The firm was among multiple winners at a record-breaking 2024 ceremony held in London on April 11
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
The Americas research cycle has commenced. Do not miss this opportunity to nominate your work!
Increased and new patent fees could affect prosecution strategies for law firms and companies, according to sources
Five former Oblon lawyers felt that joining Merchant & Gould would help them offer the right prices to entice clients
The UK may not be a UPC member but its firms are still acting in proceedings, with Carpmaels among the most prominent
Naomi Pearce of Pearce IP shares how she is helping her firm become a life sciences leader and how generous policies have helped attract top talent
The Court of Appeal has dismissed an appeal filed by Ocado, in what was a key test for transparency at the new court
Each week Managing IP speaks to a different IP lawyer or professional about their life and career
INTA is calling out ‘immoral’ unregistered attendees at the association’s annual meeting, but the debate is more nuanced
Gift this article